Intercept Pharmaceuticals
Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases.
376 employees · est. 2002 · Morristown, United States
SpyGlass Pharma, Inc.
SpyGlass is developing novel treatments for chronic ophthalmic diseases.
40 employees · est. 2019 · Aliso Viejo, United States
Intercept Pharmaceuticals is the older company (2002 vs 2019); Intercept Pharmaceuticals is the larger of the two.
Side-by-Side Comparison
| Metric | Intercept Pharmaceuticals | SpyGlass Pharma, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2002 older | 2019 |
| Headquarters | ||
| Headquarters | Morristown, United States | Aliso Viejo, United States |
| Employees | ||
| Employees | 376 larger | 40 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Pharmaceutical, Logistics and Delivery |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Series C |
| Total Funding | ||
| Total Funding | $970.05M | $109.78M |
| Funding Rounds | ||
| Funding Rounds | 8 | 3 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Liver Diseases, Rare Diseases, Drug Development, Therapeutics, Chronic Autoimmune Liver Diseases, Small Molecule Drugs, Fibrotic Diseases, Metabolic Diseases, Bile Acid Receptors, Chronic Liver Diseases, Non-viral Liver Diseases, Innovation | Ophthalmic Diseases, Treatments, Chronic Diseases, Pharmaceuticals, Sue Anschutz-Rodgers Eye Center, University Of Colorado School Of Medicine, Dr. Malik Y. Kahook, Glenn Sussman, Startup, Innovation, Medical Innovation |
| Website | ||
| Website | interceptpharma.com | spyglasspharma.com |
About Intercept Pharmaceuticals
Intercept Pharmaceuticals, founded in 2002, is a biopharmaceutical company focused on developing novel therapeutics to treat rare and serious liver diseases such as primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). The company's last investment of $447.70M in Post-IPO...
About SpyGlass Pharma, Inc.
SpyGlass Pharma, Inc. is a pharmaceutical startup that is focused on developing novel treatments for chronic ophthalmic diseases. Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman, the company is based in the United States and was established in 2019. Their technology, which originates from th...
We will tell you when either one moves
BounceWatch watches Intercept Pharmaceuticals and SpyGlass Pharma, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Intercept Pharmaceutic... and SpyGlass Pharma, Inc. — by email.
Frequently Asked Questions
Compare Intercept Pharmaceuticals with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Intercept Pharmaceuticals on 12 Sep 2024, and SpyGlass Pharma, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
